Benitec Biopharma (BNTC)
(Delayed Data from NSDQ)
$8.93 USD
+0.27 (3.12%)
Updated Aug 9, 2024 03:40 PM ET
After-Market: $8.90 -0.03 (-0.34%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/19/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -1.64 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
8.62% |
---|---|
Current Year | -6.56 |
Next Year | -2.35 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | 0.00M | 0.12M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.66 | -6.56 | -2.35 |
# of Estimates | 2 | 1 | 2 | 2 |
Most Recent Consensus | -0.53 | NA | -5.45 | -1.81 |
High Estimate | -0.53 | -0.66 | -5.45 | -1.81 |
Low Estimate | -0.63 | -0.66 | -7.67 | -2.88 |
Year ago EPS | NA | -2.76 | -14.12 | -6.56 |
Year over Year Growth Est. | NA | 76.09% | 53.54% | 64.25% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.66 | -6.56 | -2.35 |
7 Days Ago | -0.58 | -0.66 | -6.56 | -2.35 |
30 Days Ago | -0.63 | -0.66 | -7.67 | -2.88 |
60 Days Ago | NA | NA | NA | NA |
90 Days Ago | NA | NA | NA | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.53 | -0.66 | -5.45 | -1.81 |
Zacks Consensus Estimate | -0.58 | -0.66 | -6.56 | -2.35 |
Earnings ESP | 8.62% | 0.00% | 16.92% | 22.81% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.64 | -2.64 | -2.76 | NA | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more